Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 181

1.
2.

Human resources requirements for highly active antiretroviral therapy scale-up in Malawi.

Muula AS, Chipeta J, Siziya S, Rudatsikira E, Mataya RH, Kataika E.

BMC Health Serv Res. 2007 Dec 19;7:208.

3.

Approaches to rationing antiretroviral treatment: ethical and equity implications.

Bennett S, Chanfreau C.

Bull World Health Organ. 2005 Jul;83(7):541-7.

4.

Coverage of highly active antiretroviral therapy among postpartum women in Malawi.

Kumwenda J, Matchere F, Mataya R, Chen S, Mipando L, Li Q, Kumwenda NI, Taha TE.

Int J STD AIDS. 2011 Jul;22(7):368-72. doi: 10.1258/ijsa.2011.010359.

PMID:
21729953
5.

Understanding reasons for treatment interruption amongst patients on antiretroviral therapy--a qualitative study at the Lighthouse Clinic, Lilongwe, Malawi.

Tabatabai J, Namakhoma I, Tweya H, Phiri S, Schnitzler P, Neuhann F.

Glob Health Action. 2014 Sep 30;7:24795. doi: 10.3402/gha.v7.24795. eCollection 2014.

6.

Suboptimal patterns of provider initiated HIV testing and counselling, antiretroviral therapy eligibility assessment and referral in primary health clinic attendees in Blantyre, Malawi.

MacPherson P, Lalloo DG, Choko AT, Mann GH, Squire SB, Mwale D, Manda E, Makombe SD, Desmond N, Heyderman R, Corbett EL.

Trop Med Int Health. 2012 Apr;17(4):507-17. doi: 10.1111/j.1365-3156.2011.02946.x. Epub 2012 Feb 1.

7.

Cost-effectiveness of highly active antiretroviral therapy in South Africa.

Badri M, Maartens G, Mandalia S, Bekker LG, Penrod JR, Platt RW, Wood R, Beck EJ.

PLoS Med. 2006 Jan;3(1):e4. Epub 2005 Dec 6.

8.

Act local, think global: how the Malawi experience of scaling up antiretroviral treatment has informed global policy.

Harries AD, Ford N, Jahn A, Schouten EJ, Libamba E, Chimbwandira F, Maher D.

BMC Public Health. 2016 Sep 6;16:938. doi: 10.1186/s12889-016-3620-x.

9.

Pregnant women's access to PMTCT and ART services in South Africa and implications for universal antiretroviral treatment.

Hussain A, Moodley D, Naidoo S, Esterhuizen TM.

PLoS One. 2011;6(12):e27907. doi: 10.1371/journal.pone.0027907. Epub 2011 Dec 5.

10.

Factors associated with timely initiation of antiretroviral therapy in two HIV clinics in Lilongwe, Malawi.

Johnson DC, Feldacker C, Tweya H, Phiri S, Hosseinipour MC.

Int J STD AIDS. 2013 Jan;24(1):42-9. doi: 10.1177/0956462412472312. Epub 2013 May 6.

PMID:
23467293
11.

Prevalence and predictors of highly active antiretroviral therapy use in patients with HIV infection in the united states. HCSUS Consortium. HIV Cost and Services Utilization.

Cunningham WE, Markson LE, Andersen RM, Crystal SH, Fleishman JA, Golin C, Gifford A, Liu HH, Nakazono TT, Morton S, Bozzette SA, Shapiro MF, Wenger NS.

J Acquir Immune Defic Syndr. 2000 Oct 1;25(2):115-23.

PMID:
11103041
12.

Access to highly active antiretroviral therapy (HAART) for women and children in the WHO European Region 2002-2006.

Stengaard AR, Lazarus JV, Donoghoe MC, Nielsen S, Matic S.

AIDS Care. 2009 Jul;21(7):893-902. doi: 10.1080/09540120802537872.

PMID:
20024746
13.

CD4 testing at clinics to assess eligibility for antiretroviral therapy.

Lumala R, van den Akker T, Metcalf CA, Diggle E, Zamadenga B, Mbewa K, Akkeson A.

Malawi Med J. 2012 Jun;24(2):25-8.

14.

"Can't you initiate me here?": Challenges to timely initiation on antiretroviral therapy among methadone clients in Dar es Salaam, Tanzania.

Saleem HT, Mushi D, Hassan S, Bruce RD, Cooke A, Mbwambo J, Lambdin BH.

Int J Drug Policy. 2016 Apr;30:59-65. doi: 10.1016/j.drugpo.2015.12.009. Epub 2015 Dec 19.

15.

Accessibility of antiretroviral therapy in Ghana: convenience of access.

Addo-Atuah J, Gourley D, Gourley G, White-Means SI, Womeodu RJ, Faris RJ, Addo NA.

SAHARA J. 2012;9(2):74-87. doi: 10.1080/17290376.2012.683581.

PMID:
23237042
16.

Gender and the use of antiretroviral treatment in resource-constrained settings: findings from a multicenter collaboration.

Braitstein P, Boulle A, Nash D, Brinkhof MW, Dabis F, Laurent C, Schechter M, Tuboi SH, Sprinz E, Miotti P, Hosseinipour M, May M, Egger M, Bangsberg DR, Low N; Antiretroviral Therapy in Lower Income Countries (ART-LINC) study group.

J Womens Health (Larchmt). 2008 Jan-Feb;17(1):47-55. doi: 10.1089/jwh.2007.0353.

PMID:
18240981
17.

Using concept mapping to explore why patients become lost to follow up from an antiretroviral therapy program in the Zomba District of Malawi.

Rachlis B, Ahmad F, van Lettow M, Muula AS, Semba M, Cole DC.

BMC Health Serv Res. 2013 Jun 11;13:210. doi: 10.1186/1472-6963-13-210.

18.

On the front line of HIV virological monitoring: barriers and facilitators from a provider perspective in resource-limited settings.

Rutstein SE, Golin CE, Wheeler SB, Kamwendo D, Hosseinipour MC, Weinberger M, Miller WC, Biddle AK, Soko A, Mkandawire M, Mwenda R, Sarr A, Gupta S, Mataya R.

AIDS Care. 2016;28(1):1-10. doi: 10.1080/09540121.2015.1058896. Epub 2015 Aug 17.

19.

ART access-related barriers faced by HIV-positive persons linked to care in southern Ghana: a mixed method study.

Ankomah A, Ganle JK, Lartey MY, Kwara A, Nortey PA, Okyerefo MP, Laar AK.

BMC Infect Dis. 2016 Dec 7;16(1):738.

20.

Estimating the need for antiretroviral treatment and an assessment of a simplified HIV/AIDS case definition in rural Malawi.

McGrath N, Kranzer K, Saul J, Crampin AC, Malema S, Kachiwanda L, Zaba B, Jahn A, Fine PE, Glynn JR.

AIDS. 2007 Nov;21 Suppl 6:S105-13.

PMID:
18032933

Supplemental Content

Support Center